ANA's capital raise is finally here, and as we had warned, it turns out to be rather bigger than the ¥200bn the Nikkei had suggested. JAL benefitted from timely vaccine news. ANA probably will not.
SUMMARY
(Sign Up to Access)
Begin exploring Smartkarma's AI-augmented investing intelligence platform with a complimentary Preview Pass to:
Unlock research summaries
Follow top, independent analysts
Receive personalised alerts
Access Analytics, Events and more
Join 55,000+ investors, including top global asset managers overseeing $13+ trillion.